Results 211 to 220 of about 984,362 (340)
Medial Arterial Calcification: An Overlooked Player in Peripheral Arterial Disease.
C. Ho, C. Shanahan
semanticscholar +1 more source
This review redefines the carotid bulb (CB) as a variable geometric dilation shaped by hemodynamics and the carotid sinus (CS) as a conserved neurohistological baroreceptor field. Distinguishing these entities clarifies a century of anatomical confusion and links geometry, neurohistology, and clinical interpretation within a unified framework ...
Răzvan Costin Tudose +2 more
wiley +1 more source
From hospital to primary care: the importance of coordinated care in peripheral arterial disease: a commentary. [PDF]
Garmy P.
europepmc +1 more source
L. Pérez de Isla +20 more
semanticscholar +1 more source
Interlukin‐5 (IL‐5) plays a crucial role in the pathogenesis of eosinophilic granulomatosis with polyangiitis (EGPA) by promoting eosinophil differentiation, activation, and survival. We present here a typical case of EGPA in which treatment with IL‐5 pathway inhibitors is prescribed, showing to be beneficial for the patient.
Alvise Berti, Christian Pagnoux
wiley +1 more source
PM<sub>2.5</sub> and its chemical components interact with hypoxia to increase the risk of hospitalization for peripheral arterial disease. [PDF]
He L +10 more
europepmc +1 more source
Objectives The aim of this study is to generate hypotheses about unknown drugs associated with the onset or worsening of Raynaud's phenomenon (RP) and to explore their potential pathophysiologic mechanisms through a mixed disproportionality/clustering analysis from the World Health Organization (WHO) pharmacovigilance database.
Alex Hlavaty +4 more
wiley +1 more source
Increased risk for severe peripheral arterial disease in Kabuki syndrome. [PDF]
D'Andrea MM, Leon LR.
europepmc +1 more source
Objective Antiphospholipid syndrome (APS) is a thromboinflammatory disorder characterized by clinical and mechanistic heterogeneity that complicates early diagnosis and hinders targeted treatment. We aimed to identify distinct molecular endotypes among antiphospholipid antibody (aPL)–positive patients using whole‐blood transcriptomics.
Amala Ambati +13 more
wiley +1 more source

